Stock Taper 
RHENMAN & PARTNERS ASSET MANAGEMENT AB
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Nektar Therapeutics | NKTR | 141.25K | $9.86M |
 AMN Healthcare Services, Inc. | AMN | 144.47K | $4.68M |
 Medtronic plc | MDT | 145K | $11.34M |
 AstraZeneca PLC | AZN | 151.5K | $28.48M |
 Insmed Incorporated | INSM | 151.96K | $16.2M |
 DexCom, Inc. | DXCM | 160K | $10.78M |
 LivaNova PLC | LIVN | 164K | $13.49M |
 BrightSpring Health Services, Inc. Common Stock | BTSG | 165.9K | $11.57M |
 Gilead Sciences, Inc. | GILD | 178.25K | $22.52M |
 Waystar Holding Corp. | WAY | 178.57K | $3.67M |
 Denali Therapeutics Inc. | DNLI | 179K | $4.6M |
 Alkermes plc | ALKS | 185.25K | $9.71M |
 Royalty Pharma plc | RPRX | 197K | $11.05M |
 Merck & Co., Inc. | MRK | 213.5K | $27.43M |
 Ocular Therapeutix, Inc. | OCUL | 225K | $2.21M |
 Centene Corp. | CNC | 244K | $15.66M |
 Edwards Lifesciences Corporation | EW | 260K | $23.52M |
 CVS Health Corp. | CVS | 279.37K | $28.9M |
 BioMarin Pharmaceutical Inc. | BMRN | 290.5K | $16.62M |
 Stevanato Group S.p.A. | STVN | 305.97K | $5.53M |